Related Experiment Video
Updated: Mar 24, 2026

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
Published on: July 30, 2020
The Aurora kinase inhibitors in cancer research and therapy
Jonas Cicenas1,2,3
1CALIPHO Group, Swiss Institute of Bioinformatics, CMU-1, rue Michel Servet, 1211, Geneva 4, Switzerland. j.cicenas@mapkinases.eu.
Abstract:
Compounds that affect enzymatic function of kinases are valuable for the understanding of the complex biochemical processes in cells. Aurora kinases (AURKs) play a key role in the control of the mitosis. These kinases are frequently deregulated in different human cancers: overexpression, amplifications, translocations and deletions were reported in many cancer cell lines as well as patient tissues. These findings steered a rigorous hunt for small-molecule AURK inhibitors not only for research purposes as well as for therapeutic uses. In this review, we describe a number of AURK inhibitors and their use in cancer research and/or therapy. We hope to assist researchers and clinicians in deciding which inhibitor is most appropriate for their specific purpose. The review will also provide a broad overview of the clinical studies performed with some of these inhibitors (if such studies have been performed).
Insights
Small-molecule inhibitors targeting Aurora kinases (AURKs) are crucial for understanding cell division and treating cancers where these enzymes are deregulated. This review details AURK inhibitors for research and therapeutic applications.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Kinase inhibitors are vital tools for studying cellular biochemical processes.
- Aurora kinases (AURKs) are critical regulators of mitosis.
- AURK deregulation (overexpression, amplification, etc.) is common in human cancers.
Purpose of the Study:
- To review small-molecule Aurora kinase (AURK) inhibitors.
- To discuss their applications in cancer research and therapy.
- To aid researchers and clinicians in selecting appropriate inhibitors.
Main Methods:
- Literature review of existing Aurora kinase inhibitors.
- Analysis of their roles in cancer research.
- Overview of clinical studies involving these inhibitors.
Main Results:
- Identified various small-molecule inhibitors targeting AURKs.
- Highlighted their utility in cancer research models.
- Summarized clinical trial data for select inhibitors.
Conclusions:
- Small-molecule AURK inhibitors are valuable for both fundamental research and cancer treatment.
- The review provides guidance for selecting specific inhibitors.
- Further clinical investigation of AURK inhibitors is warranted.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies

